$6.44
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Healthcare Triangle Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in Pleasanton, California and currently employs 40 full-time employees. The company went IPO on 2021-10-01. Healthcare Triangle, Inc. is a healthcare information technology company. The firm is focused on advancing innovative, industry-transforming solutions in the areas of cloud services, data science, professional and managed services for the Healthcare and Life Sciences industry. Its Software Services segment provides strategic advisory, implementation, and development services. Its Managed Services and Support segment includes post-implementation support and cloud hosting. Its Customer Engagement Services provide customer search, marketing, telemarketing and customer-support services to financial institutions, insurance companies and intermediaries, and other customers. The firm's proprietary platforms include CloudEz, DataEz, Readabl.AI, Ziloy, and Ezovion. Through its platform, solutions, and services, the Company supports healthcare delivery organizations, healthcare insurance companies, pharmaceutical, and life sciences, biotech companies, and medical device manufacturers.
Country

US

CEO

Mr. Shibu Kizhakevilayil

IPO date

2021

Employees

40

ISIN

US42227W5040

Key stats

Open

$6.43

Volume

18.84K

Market cap

$6.03M

Prev. close

$6.43

Impl / hst vl

-

Open interest

$0.00

$6.43

Day’s Range

$6.44

$0.14

52W Range

$9.97

Valuation

38
Valuation score
Overvalued
P/E
-
P/S
0.23
P/B
0.12
Current ratio
0.60
Debt / Equity
0.24
ROE
-56.42%
Gross margin
22.48%
Income growth
-28.77%
FCF growth
-87.45

Analysts estimates

Consensus rating
Buy

The average rating from top 4 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$3.21
The top 3 analysts forecasts that 12-month price may decrease by 50.11%, with a low of $3.18 and a high of $3.31
$3.18
Low
$3.21
Avg
$3.31
High
Current price

Earnings

Q2 ‘26 revenue
$9.19M
Q2 ‘26 net income
-$4.42M
Revenue
Net income
Previous EPS
-$150.07
Estimate EPS
-$3.50
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply